Citation of paper, Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Matti Aapro1844,2884.7
Alexandre Rocha Sepriano1612,89413.1
Louise Falzon1849,34637.3
Maarten de Wit11089,17217.6
Yeong Wook Song11343,3183.6
Andriy Krendyukov1452891.7

Journals Citing This Paper

JournalCiting PapersJournal's IFJournal's Star
BioDrugs17.9★★
Expert Opinion on Biological Therapy15.4★★
Annals of the Rheumatic Diseases12.4★★